Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2010076413) METHOD FOR EVALUATING THE IMMUNOGENICITY OF PROTEINS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/076413 International Application No.: PCT/FR2009/001424
Publication Date: 08.07.2010 International Filing Date: 15.12.2009
IPC:
G01N 33/68 (2006.01)
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68
involving proteins, peptides or amino acids
Applicants:
PROTEUS [FR/FR]; Parc Georges Besse 70, allée Graham Bell F-30000 Nimes, FR (AllExceptUS)
COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES [FR/FR]; 25, rue Leblanc Bâtiment « Le Ponant D » F-75015 Paris, FR (AllExceptUS)
MAILLERE, Bernard [FR/FR]; FR (UsOnly)
DELLUC-DESROCHES, Stéphanie [FR/FR]; FR (UsOnly)
Inventors:
MAILLERE, Bernard; FR
DELLUC-DESROCHES, Stéphanie; FR
Agent:
CABINET ORES; 36, rue de Saint Pétersbourg F-75008 Paris, FR
Priority Data:
080712318.12.2008FR
Title (EN) METHOD FOR EVALUATING THE IMMUNOGENICITY OF PROTEINS
(FR) PROCEDE D'EVALUATION DE L'IMMUNOGENICITE DES PROTEINES
Abstract:
(EN) The invention relates to a method for evaluating the immunogenicity of proteins in humans or animals, comprising analysing the CD4+ T lymphocyte response specific to the protein to be tested in individuals of the (human or animal) species in which the immunogenicity of said cell is analysed.
(FR) Procédé d'évaluation de l'immunogénicité des protéines chez l'homme ou l'animal, reposant sur l'analyse de la réponse lymphocytaire T CD4+ spécifique de la protéine à tester chez des individus de l'espèce (humaine ou animale) dans laquelle l'immunogénicité de ladite protéine est analysée.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: French (FR)
Filing Language: French (FR)
Also published as:
EP2376925US20110275098FR2940451